Choline incorporation into MCF7 tumour cells: Correlation with proliferation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 6, 2005, Pages 660-667

  Al Saeedi, Fatma ^a   Welch, Andy E ^a   Smith, Tim A D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Choline; PET; Phosphocholine; Tumour

Indexed keywords

METHYLCHOLINE H 3; PHOSPHOLIPID; THYMIDINE; TRACER; UNCLASSIFIED DRUG; CARBON; CHOLINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL CYCLE S PHASE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CORRELATION ANALYSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ISOLATION; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; METABOLITE; METASTASIS; PLASMA CLEARANCE; SIMULATION; THIN LAYER CHROMATOGRAPHY; BREAST TUMOR; CELL PROLIFERATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; STATISTICS; TUMOR CELL LINE;

BREAST NEOPLASMS; CARBON RADIOISOTOPES; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLINE; HUMANS; METABOLIC CLEARANCE RATE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STATISTICS;

EID: 21244439017     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1707-6     Document Type: Article

References (41)

1. Negendank W. Studies of human tumors by MRS - a review. NMR Biomed 1992;5:303-24.
2. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-4.
3. Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 1996;56:4630-5.
4. Kotzerke J, Prang J, Neumaier B, Volkmer B, Guhlmann A, Kleinschmidt K, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000;27:1415-9.
5. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001;28:1664-70.
6. Kobori D, Kirihara Y, Kosaka N, Kara T. Positron emission tomography of esophageal carcinoma using C-11-choline and F-18-fluorodeoxyglucose - a novel method of preoperative lymph node staging. Cancer 1999;86:1638-48.
7. Hara T, Inagaki K, Kosaka N, Morita T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with C-11-choline PET. J Nucl Med 2000;41:1507-13.
8. Liu D, Hutchinson OC, Osman S, Price P, Workman P, Aboagye EO. Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin. Br J Cancer 2002;87:783-9.
9. Zeisel SH. Choline phospholipids - signal transduction and carcinogenesis FASEB J 1993;7:551-7.
10. Wettstein M, Weik C, Holneicher C, Haussinger D. Betaine as an osmolyte in rat liver: metabolism and cell-to-cell interactions. Hepatology 1998;27:787-93.
11. Tijburg LBM, Geelen MJH, Vangolde LMG. Biosynthesis of phosphatidylethanolamine via the CDP-ethanolamine route is an important pathway in isolated rat hepatocytes. Biochem Biophys Res Commun 1989;160:1275-80.
12. Kalra R, Wade KE, Hands L, Styles P, Camplejohn R, Greenall M, et al. Phosphomonoester is associated with proliferation in human breast cancer - a P-31 MRS study. Br J Cancer 1993;67:1145-53.
13. Smith TAD, Eccles S, Ormerod MG, Tombs AJ, Titley JC, McCready VR. The phospholcholine and glycerophosphorylcholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth. Br J Cancer 1991;64:821-6.
14. Daly PF, Lyon RC, Faustino PJ, Cohen JS. Phospholipid metabolism in cancer cells monitored by P-31 NMR-spectroscopy. J Biol Chem 1987;262:14875-8.
15. Smith TAD, Eccles S, Box G, Titley JC, Leach MO, McCready VR. Phosphocholine content of rat sarcoma cells in the presence and absence of serum. Anticancer Res 1996;16: 1389-92.
16. 31P NMR spectra from human breast tumours: variations in phosphorus metabolism. Br J Cancer 1991;63:514-6.
17. Warden CH, Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985;260:6006-11.
18. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-C-11]choline. J Nucl Med 1997;38:842-7.
19. 11C]choline; implications for in-vivo imaging with positron emission tomography. Eur J Nucl Med 2000;27:25-32.
20. Graham RA, Meyer RA, Szwergold BS, Brown TR. Observation of myoinositol 1,2-(cyclic) phosphate in a Morris hepatoma by P-31 NMR. J Biol Chem 1987;262:35-7.
21. Ramirez de Molina A, Gutierrez R, Ramos MA, Silva JM, Silva J, Bonilla F, et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 2002;21:4317-22.
22. Liscovitch M, Freese A, Blusztajn JK, Wurtman RJ. High performance liquid chromatography of water-soluble choline metabolites. Anal Biochem 1985;151:182-7.
23. Hoffmann K, Grafe F, Wohlrab W, Neubert RH, Brandsch M. Functional characterization of a high-affinity choline transport system in human keratinocytes. J Invest Dermatol 2002;119:118-21.
24. Chung TW, Huang JS, Mukherjee JJ, Crilly KS, Kiss Z. Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell Signal 2000;12:279-88.
25. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 2002;62:1966-70.
26. Warden CH, Friedkin M. Regulation of phosphatjdylcholine biosynthesis by mitogenic growth factors. Biochim Biophys Acta 1984;792:270-80.
27. Paddon HB, Vigo C, Vance DE. Diethylstilbestrol treatment increases the amount of choline kinase in rooster liver. Biochim Biophys Acta 1982;710:112-5.
28. Ko KWS, Cook HW, Vance DE. Reduction of phosphatidylcholine turnover in a nb-2 lymphoma cell line after prolactin treatment - a novel mechanism for control of phosphatidylcholine levels in cells. J Biol Chem 1986;261:7846-52.
29. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996;16:1375-80.
30. 1H-MRS. J Neurooncol 2003;62:329-38.
31. Lockman PR, Allen DD. The transport of choline. Drug Dev Ind Pharm 2002;28:749-71.
32. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994;372:549-52.
33. Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Ann Rev Physiol 1998;60:243-66.
34. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 1997;16:871-81.
35. Sinclair CJ, Chi KD, Subramanian V, Ward KL, Green RM. Functional expression of a high affinity mammalian hepatic choline/organic transporter. J Lipid Res 2000;41:1841-48.
36. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 1996;271:32599-604.
37. Okuda M, Urakami Y, Saito H, Inui K-I. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes. Biochim Biophys Acta 1999;1417:224-31.
38. Wonderlin WF, Woodfork KA, Strobl JS. Changes in membrane potential during the progression of MCF7 human mammary tumor cells through the cell cycle. J Cell Physiol 1995;165:177-85.
39. 18F-labeled choline analogues as oncologic PET tracers. J Nucl Med 2001;42:1805-14.
40. 18F-labeled choline analogues as an oncologic for positron emission tomography: initial findings in prostate cancer. Cancer Res 2000;61:110-7.
41. 18F-fluorocholine. J Nucl Med 2002;43:92-6.